Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06512922
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Adaptive Cognitive Training on Cognitive Function in Elderly Hypertension Patients in the Community
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Effects of COgNitive Training in Community-dwelling Older Adults at High Risk for demENTia and With Hypertension CONTENT-Hypertension a Randomized Placebo-controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective A growing body of evidence supports hypertension as a risk factor for cognitive decline Hypertension is significantly associated with accelerated cognitive decline poorer cognitive function and mild cognitive impairment and dementia Cognitive training is an effective intervention to improve cognitive function However the current cognitive training does not fully consider the different areas and degrees of cognitive function impairmentof older adults This study aims to evaluate the effect of adaptive cognitive training on cognitive function of older adults with hypertension in the community
Participants Age 60 years or older diagnosis of hypertension and cognitive function assessment showed no dementia
Design The study was designed as a double-blind randomized controlled trial 120 hypertension participants without dementia aged 60 years or older in Shijingshan Beijing were included Participants will be randomized to adaptive cognitive training intervention group and placebo cognitive training control group at a ratio of 11 Both training will be delivered by using PADs with the same appearance The interventions will last for 6 months and follow up to 12 months and both groups will be followed up on the same time schedules for all outcome measurements The primary outcome is changes in MoCA scores from baseline to the end of the 6-month intervention
The current trial has been reviewed by the Ethics Committee of Plastic Surgery Hospital Chinese Academy of Medical Sciences Peking Union Medical College approval number 2024-162
Participants Age 60 years or older diagnosis of hypertension and cognitive function assessment showed no dementia
Design The study was designed as a double-blind randomized controlled trial 120 hypertension participants without dementia aged 60 years or older in Shijingshan Beijing were included Participants will be randomized to adaptive cognitive training intervention group and placebo cognitive training control group at a ratio of 11 Both training will be delivered by using PADs with the same appearance The interventions will last for 6 months and follow up to 12 months and both groups will be followed up on the same time schedules for all outcome measurements The primary outcome is changes in MoCA scores from baseline to the end of the 6-month intervention
The current trial has been reviewed by the Ethics Committee of Plastic Surgery Hospital Chinese Academy of Medical Sciences Peking Union Medical College approval number 2024-162
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None